Total Payments
$2,623
2024 Payments
$451.31
Companies
11
Transactions
36
Medicare Patients
753
Medicare Billing
$77,366
Payment Breakdown by Category
Other$1,375 (52.4%)
Food & Beverage$1,248 (47.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,375 | 1 | 52.4% |
| Food and Beverage | $1,248 | 35 | 47.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,553 | 5 | $0 (2023) |
| Novo Nordisk Inc | $396.08 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $242.35 | 9 | $0 (2024) |
| Alkermes, Inc. | $132.19 | 2 | $0 (2024) |
| Allergan, Inc. | $120.25 | 2 | $0 (2022) |
| Orexo US, Inc. | $54.67 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $35.72 | 2 | $0 (2020) |
| Lilly USA, LLC | $28.50 | 1 | $0 (2023) |
| Indivior Inc. | $24.20 | 1 | $0 (2024) |
| Organogenesis Inc. | $20.81 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $451.31 | 8 | Novo Nordisk Inc ($276.82) |
| 2023 | $361.94 | 15 | Otsuka America Pharmaceutical, Inc. ($219.11) |
| 2022 | $1,734 | 8 | ABBVIE INC. ($1,504) |
| 2020 | $35.72 | 2 | Janssen Pharmaceuticals, Inc ($35.72) |
| 2019 | $27.89 | 2 | Orexo US, Inc. ($27.89) |
| 2018 | $12.08 | 1 | Orexo US, Inc. ($12.08) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $108.37 | General |
| Category: Obesity | ||||||
| 04/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Obesity | ||||||
| 04/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $112.14 | General |
| Category: CNS | ||||||
| 03/15/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: OUD | ||||||
| 01/31/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neurology | ||||||
| 12/15/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: CNS | ||||||
| 09/11/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: PSYCHIATRY | ||||||
| 06/15/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: PSYCHIATRY | ||||||
| 05/03/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PSYCHIATRY | ||||||
| 04/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Obesity | ||||||
| 03/03/2023 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Addiction Medicine | ||||||
| 03/02/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $109.55 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Obesity | ||||||
| 01/21/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: PSYCHIATRY | ||||||
| 01/12/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $109.78 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 168 | 204 | $26,855 | $13,820 |
| 2022 | 6 | 200 | 240 | $34,465 | $17,195 |
| 2021 | 7 | 144 | 341 | $47,661 | $24,117 |
| 2020 | 5 | 241 | 288 | $43,365 | $22,234 |
Total Patients
753
Total Services
1,073
Medicare Billing
$77,366
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 89 | $13,350 | $7,892 | 59.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 47 | $9,165 | $4,230 | 46.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 24 | $3,240 | $1,429 | 44.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 43 | 44 | $1,100 | $268.75 | 24.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 73 | 107 | $16,050 | $8,036 | 50.1% |
| 99234 | Hospital observation or inpatient care admitted and discharged on the same day for low severity problem, typically 40 minutes | Facility | 2022 | 29 | 30 | $6,240 | $3,022 | 48.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $5,070 | $2,649 | 52.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $3,600 | $2,227 | 61.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 18 | $2,430 | $995.36 | 41.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 40 | 43 | $1,075 | $265.37 | 24.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 21 | 200 | $26,890 | $13,749 | 51.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 36 | 47 | $7,050 | $3,733 | 52.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 33 | 35 | $6,825 | $3,210 | 47.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $2,475 | $1,667 | 67.3% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 14 | 14 | $1,921 | $842.88 | 43.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 15 | $2,025 | $790.10 | 39.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 16 | 19 | $475.00 | $125.02 | 26.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 63 | 67 | $12,735 | $6,525 | 51.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 53 | 69 | $10,350 | $5,442 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 34 | 34 | $7,650 | $5,133 | 67.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 88 | $11,880 | $4,933 | 41.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 29 | 30 | $750.00 | $201.76 | 26.9% |
About Dr. Jyoti Chawla, MD
Dr. Jyoti Chawla, MD is a Internal Medicine healthcare provider based in Powell, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528159241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jyoti Chawla, MD has received a total of $2,623 in payments from pharmaceutical and medical device companies, with $451.31 received in 2024. These payments were reported across 36 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,375).
As a Medicare-enrolled provider, Chawla has provided services to 753 Medicare beneficiaries, totaling 1,073 services with total Medicare billing of $77,366. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Powell, OH
- Active Since 09/27/2006
- Last Updated 05/01/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528159241
Products in Payments
- UBRELVY (Drug) $1,534
- Wegovy (Drug) $307.44
- ABILIFY MAINTENA (Drug) $171.42
- VIVITROL (Drug) $112.14
- BOTOX (Biological) $102.44
- Saxenda (Drug) $70.13
- Zubsolv (Drug) $54.67
- ABILIFY ASIMTUFII (Drug) $54.05
- SPRAVATO (Drug) $35.72
- JARDIANCE (Drug) $28.50
- SUBLOCADE (Drug) $24.20
- Puraply (Medical Supply) $20.81
- ARISTADA (Drug) $20.05
- QULIPTA (Drug) $19.17
- Rybelsus (Drug) $18.51
- REXULTI (Drug) $16.88
- UZEDY (Drug) $14.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Powell
Dr. Miteshkumar Solanki, Md, MD
Internal Medicine — Payments: $10,799
Internal Medicine $10,799
Fahd Chaudhry, Md, MD
Internal Medicine — Payments: $9,599
Internal Medicine $9,599
Glen Hall, Md, MD
Internal Medicine — Payments: $3,438
Internal Medicine $3,438
Stephen Lorino, Md, MD
Internal Medicine — Payments: $2,781
Internal Medicine $2,781
James Griffin, Do, DO
Internal Medicine — Payments: $2,777
Internal Medicine $2,777
John Vannoy, Md, MD
Internal Medicine — Payments: $2,623
Internal Medicine $2,623